Merck & Co. Inc.·4

Nov 4, 5:53 PM ET

Koestler Thomas P 4

4 · Merck & Co. Inc. · Filed Nov 4, 2009

Insider Transaction Report

Form 4
Period: 2009-11-03
Koestler Thomas P
Executive Vice President
Transactions
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03240,0000 total
    Exercise: $31.57Exp: 2014-04-30Common Shares (240,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03100,0000 total
    Exercise: $20.70Exp: 2015-04-24Common Shares (100,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03220,0000 total
    Exercise: $18.85Exp: 2015-04-30Common Shares (220,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03150,0000 total
    Exercise: $16.12Exp: 2013-08-17Common Shares (150,000 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2009-11-0370,0000 total
    Exercise: $18.20Exp: 2014-02-22Common Shares (70,000 underlying)
  • Disposition to Issuer

    Common Shares

    2009-11-0359,6660 total
  • Disposition to Issuer

    Option (right to buy)

    2009-11-0390,0000 total
    Exercise: $19.23Exp: 2013-05-18Common Shares (90,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03209,7000 total
    Exercise: $22.91Exp: 2016-04-30Common Shares (209,700 underlying)
  • Disposition to Issuer

    Deferred Stock Unit Award

    2009-11-0375,0000 total
    Exercise: $0.00Common Shares (75,000 underlying)
Footnotes (6)
  • [F1]Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
  • [F2]Each deferred stock unit ("DSU") is the economic equivalent of one share of common stock.
  • [F3]The DSU's became vested upon the closing of the Merger.
  • [F4]In connection with the Merger, the cash value of the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan.
  • [F5]The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
  • [F6]Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement.

Documents

2 files
  • 4
    c91879_4x1.xmlPrimary

    MAIN DOCUMENT DESCRIPTION

  • EX-24

    POWER OF ATTORNEY